| Literature DB >> 23946801 |
Ming Zhou1, Huilin Yang, Kangwu Chen, Genlin Wang, Jian Lu, Yiming Ji, Chunshen Wu, Chao Chen, Hai Hu.
Abstract
The pre-operative embolization of hypervascular spinal tumors is often performed to decrease intraoperative blood loss and facilitate tumor resection; however, few studies have been published on its effectiveness in giant cell tumors (GCT) of the sacrum and spine. The purpose of the present study was to investigate the value of surgical excision with pre-operative transarterial embolization for GCTs of the sacrum and spine, and to evaluate the follow-up outcomes. A retrospective study was performed on 28 patients with GCTs of the sacrum and spine, who underwent surgical treatment combined with pre-operative transarterial embolization between June 1995 and August 2011. The intraoperative blood loss, transfusion, duration of surgery, treatment, local recurrence, complications, follow-up status and functional outcome were reviewed. The average follow-up period was 86.3 months (range, 12-193 months). All the patients were treated with intralesional resection without any intraoperative shock or fatalities. The average intraoperative level of blood loss was 1,528.6 ml (range, 400-5,800 ml), the average transfusion volume was 1,514.3 ml (range, 400-6,000 ml) and the average duration of surgery was 225.4 min (range, 120-470 min). In total, eight (28.6%) patients developed recurrence and two patients succumbed. A total of eight (28.6%) patients experienced complications and 24 (85.7%) retained normal neurological function. Pre-operative embolization significantly decreases intraoperative blood loss and facilitates the maximal removal of the tumor. Pre-operative embolization followed by intralesional resection is able to achieve satisfactory local control and clinical outcomes. It is an effective technique for excising GCTs of the sacrum and spine.Entities:
Keywords: blood loss; embolization; giant cell tumor; sacrum; spine
Year: 2013 PMID: 23946801 PMCID: PMC3742592 DOI: 10.3892/ol.2013.1329
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967
Patient demographics.
| Demographic | Data |
|---|---|
| Gender, n | |
| Male | 12 |
| Female | 16 |
| Age (years), n | |
| <20 | 3 |
| 20–40 | 19 |
| >40 | 6 |
| Mean | 29.6 |
| Site, n | |
| Sacrum | 15 |
| Lumbar spine | 5 |
| Thoracic spine | 8 |
| Pre-operative neurological function, n | |
| Normal | 11 |
| Partial loss | 17 |
| Complete loss | 0 |
| Surgical approach, n | |
| A | 8 |
| P | 18 |
| A+P | 2 |
| Reconstruction, n | |
| Yes | 14 |
| No | 14 |
| Nerve root sacrificed, n | |
| Yes | 13 |
| No | 15 |
| Local recurrence, n | |
| Yes | 8 |
| No | 20 |
| Neurological function at six months, n | |
| Normal | 24 |
| Partial loss | 4 |
| Complete loss | 0 |
| Last status, n | |
| NED | 25 |
| STU | 2 |
| AWD | 1 |
A, anterior; P, posterior; NED, no evidence of disease; AWD, alive with disease; STU, succumbed to unrelated disease.
Figure 1.Digital subtraction angiography, anteroposterior view. (A) Insertion of a catheter into the internal iliac artery to take an angiogram; (B) small intratumoral arteries embolized with gelfoam particles; (C) embolization of the stem of the tumor-feeding artery using a gelfoam strip; and (D) complete embolization of all tumor-feeding arteries.
Figure 2.Angiogram prior to and following selective arterial embolization. (A) Preembolization angiogram showing hypervascular tumor blush at L3. (B) Postembolization angiogram showing no appreciable residual tumor blush, but complete devascularization of the giant cell tumor.
Blood loss, transfusion and duration of surgery.
| Variable | Patient no. | Blood loss (ml)
| Transfusion (ml)
| Surgery duration (min)
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | P-value (t-test) | Mean | SD | P-value (t-test) | Mean | SD | P-value (t-test) | ||
| Site | 0.611 | 0.641 | 0.266 | |||||||
| Sacrum | 15 | 1640.0 | 1455.4 | 1620.0 | 1472.7 | 204.7 | 104.2 | |||
| Mobile Spine | 13 | 1400.0 | 899.1 | 1392.3 | 986.1 | 249.2 | 102.7 | |||
| Time between embolization and surgery (days) | 0.372 | 0.302 | 0.140 | |||||||
| 1 | 23 | 1626.1 | 1257.8 | 1630.4 | 1308.9 | 245.0 | 110.0 | |||
| 2 | 5 | 1080.0 | 965.4 | 980.0 | 861.4 | 167.0 | 60.2 | |||
Figure 3.A 29-year-old female with a large giant cell tumor affecting the sacrum. (A) Axial CT scan showing an osteolytic lesion in the sacrum. (B) Sagittal T2-weighted MRI revealing a large soft tissue extension but no involvement of the surrounding tissue. (C) Axial and (D) sagittal CT scan of a 105 months post-surgical excision with pre-operative embolization showing no tumor recurrence. CT, computed tomography; MRI, magnetic resonance imaging.
Figure 4.A 16-year-old male with a giant cell tumor affecting the L3 vertebra. (A) Axial CT scan of the L3 vertebra showing an osteolytic lesion in the vertebral body; (B) Sagittal T2-weighted MRI revealing invasion of the mass through the posterior wall of the vertebral body into the spinal canal; (C) Anteroposterior radiograph and (D) sagittal CT scan at 73 months follow-up, showing no recurrence. CT, computed tomography; MRI, magnetic resonance imaging.